Investor Relations

DBV Technologies is a global biopharmaceutical company focused on discovering, developing, manufacturing and commercializing treatments for severe allergies


Monthly information regarding the total number of voting rights and total number of shares of the Company 


Citi’s 12th Annual Biotech Conference

Boston, MA, USA


20F- Form 2016

Investor Relations

Phone : +33 1 55 42 78 78
Fax : +33 1 43 26 10 83

Subscribe to get the latest DBV’s News